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DELIVERING CONTRACEPTIVE 
VAGINAL RINGS TO 
BREASTFEEDING WOMEN 
  
The Progesterone Vaginal Ring (PVR) is a 
user-controlled contraceptive that helps 
breastfeeding women safely and effectively 
space, delay, or limit their next pregnancy. 
For the first six months after childbirth, exclusive breastfeeding provides 
effective contraception. However, many women do not or are unable to 
exclusively breastfeed. Once a woman stops breastfeeding, begins adding 
other foods or liquids to her infant’s diet, or starts menstruating, she is at 
risk of becoming pregnant and must consider other contraceptive 
methods to meet her own family planning goals. 
Of the 213 million pregnancies that occurred across the world in 2012, it 
is estimated that roughly 40%—about 85 million—were unintended.1 
Despite this high unmet need, access to safe, effective, and affordable 
family planning methods in low-resource settings is often limited or 
nonexistent—especially for postpartum breastfeeding women. For women 
seeking to space their births or limit future pregnancies, new methods 
that do not require significant health-care resources or infrastructure can 
help address the growing demand. 
The Population Council and partners developed the PVR to help address 
the unmet need for contraception among breastfeeding women. The ring 
provides a convenient option that adds choices for new mothers and 
promotes optimal infant nutrition and health.  
 
HOW THE PVR WORKS 
The PVR releases a continuous low dose of the natural hormone 
progesterone, which reinforces the inhibitory effect of breastfeeding on 
ovulation and delays the return of the menstrual cycle, therefore 
preventing pregnancy. A woman can begin using the ring as early as four 
weeks after birth if her menstrual cycle has not returned. A single ring can 
be used for three months and can be replaced with a new ring up until 
the child’s first birthday.  
In clinical trials, the PVR was 98.5% effective in preventing pregnancy 
when used continuously by women who breastfeed at least four times a 
day, which motivates women to breastfeed regularly. The PVR is safe for 
both mothers and babies, with few side effects—some women reported 
cramping, weight gain, breast tenderness, and spotting. Most women 
report a high degree of satisfaction and acceptance using the ring. Also, 
ADVANCING NUTRITION 
AND INFANT HEALTH WITH 
THE PVR: FAST FACTS 
Breastfeeding can lead to 
improved health and 
nutrition for newborns— 
and optimal breastfeeding 
saves lives.  
As the PVR does not affect 
quality or amount of breast 
milk, it may be an attractive 
option for postpartum 
women who want a method 
that is minimally invasive, 
convenient, and discreet, 
without worrying about any 
potential impact on their 
health or the health of their 
infant.  
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ongoing research suggests women may experience other 
benefits from breastfeeding, such as reduced risk of 
ovarian and breast cancer.2-3  
Unlike other contraceptives suitable for breastfeeding 
women such as the IUD, the PVR is entirely under a 
woman’s control—offering discreet protection from 
pregnancy, and giving the woman control to insert and 
remove the ring conveniently on her own. This reduces the 
need for involvement by skilled health-care providers, who 
often are in short supply in underserved settings, including 
rural areas where timely, convenient access to quality 
health-care may be scarce. 
ADDING VALUE TO THE METHOD MIX 
Traditionally, the lactational amenorrhea method (LAM) 
has been recognized as an effective way to delay return to 
fertility in breastfeeding women by delaying a woman’s 
next menstrual cycle.4-10 However, research suggests very 
low numbers of breastfeeding women (less than 5%) report 
compliance with LAM criteria.11 
User-controlled methods such as vaginal rings represent 
an important advancement in family planning. The PVR is 
unique because it offers an accessible, easy-to-use method 
without requiring frequent trips to the pharmacy or on-
demand access to a trained health-care provider. Similarly, 
rural communities need access to products that do not 
require sophisticated methods of storage to ensure the 
product remains safe, effective, and accessible. The PVR 
does not require special preparation or refrigeration.  
PROMOTING INFANT SURVIVAL  
Nearly 7 million children under the age of 5 die each year, 
mostly due to preventable causes. And newborn deaths 
represent nearly half of all deaths in children under age 5. 
However, breastfed children have at least a six times 
greater chance of survival in the first months of life than 
nonbreastfed children, and the health benefits of 
breastfeeding are particularly critical in developing 
countries.12 The PVR not only provides contraceptive 
efficacy for new mothers, but also offers a method whereby 
the efficacy relies on optimal breastfeeding practices, 
holistically contributing to better outcomes for infants.  
INCREASING ACCESS AND MEETING 
CRITICAL DEVELOPMENT GOALS  
In 2015, countries worldwide adopted the Sustainable 
Development Goals—a set of critical goals setting the 
foundation of a new development agenda to be carried out 
over a 15-year period. The introduction of the PVR helps 
contribute to the success of several key goals including 
SDG 3 (ensuring healthy lives and promoting well-being at 
all ages) and SDG 5 (achieving gender equality and 
empowerment of all women and girls).13 
And, with sustained investment in planning the introduction 
of a new method, health sectors play a major role in 
ensuring women can access a range of products that best 
meet their needs, when and where they need them. To help 
make this a reality, product developers and partners often 
employ what’s called a “Total Market Approach.” This 
approach brings together the public and private sectors (e.g., 
social marketing groups, NGOs, and commercial 
organizations). Through a highly coordinated effort, partners 
are able to leverage resources and knowledge to reduce 
burden on the public sector, increase health-care-system 
capacity, and ensure access. 
The Population Council supports the Total Market Approach 
and is invested in generating the evidence needed to 
facilitate introduction of the PVR in sub-Saharan Africa and 
India. Researchers have been: assessing interest in and 
support for the PVR among decision-makers who determine 
which products are made available in their countries; 
determining acceptability of the ring among breastfeeding 
women, partners, providers; and streamlining pathways for 
introduction. With the addition of the PVR to the World 
Health Organization’s Essential Medicines List, local 
regulatory authorities now have more evidence supporting 
the value of introducing the PVR within their family planning 
programs. 
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